Craft
  • Home
  •  / Syneos Health
Syneos Health

Syneos Health

Backlog

$11.6 B

Q1, 2021

Revenue

$5.2 B

FY, 2021

Market Capitalization

$5 B

2022-09-22

Syneos Health Summary

Company summary

Overview
Syneos Health (formerly known as INC Research) is a contract research organization that provides various clinical development services for the biopharmaceutical and medical device industries. Its operations are divided into two segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers a variety of services spanning clinical development, including clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.
Type
Public
Founded
1998
HQ
Morrisville, NC, US | view all locations
Website
https://www.syneoshealth.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Alistair Macdonald

    Alistair Macdonald, Advisor To Chief Executive Officer

  • Jason Meggs

    Jason Meggs, Chief Financial Officer

  • Michelle Keefe

    Michelle Keefe, Chief Executive Officer

  • Lisa van Capelle

    Lisa van Capelle, Chief Human Resources Officer

Operating MetricsView all

Facilities

113
13.1%

FY, 2021

Countries

50
2.0%

FY, 2021

Backlog

$11.6B
3.7%

Q1, 2021

LocationsView all

91 locations detected

  • Morrisville, NC HQ

    United States

    1030 Sync St

  • Austin, TX

    United States

    Encino Trace Building II, 5707 Southwest Parkway, Suite 200

  • Blue Bell, PA

    United States

    1787 Sentry Pkwy W Building 18, Suite 300

  • Boston, MA

    United States

    470 Atlantic Ave 11th floor

  • Charlotte, NC

    United States

    11525 N. Community House Road

  • Irvine, CA

    United States

    2525 Main Street #300

and 85 others

Syneos Health Financials

Summary financials

Revenue (Q2, 2022)
$1.4B
Gross profit (Q2, 2022)
$325.8M
Net income (Q2, 2022)
$77.7M
Cash (Q2, 2022)
$106.0M
EBIT (Q2, 2022)
$116.6M
Enterprise value
$8.0B

Footer menu